National registry of thoracoamniotic shunting using a double‐basket catheter: A post‐marketing surveillance registry of 295 patients with fetal hydrothorax

Abstract

AbstractObjectiveWe report on the 1‐year outcomes of fetuses who underwent thoracoamniotic shunting (TAS) with a double‐basket catheter for fetal hydrothorax (FHT) using a national post‐marketing surveillance registry.MethodsThis surveillance study was conducted for cases enrolled between 2011 and 2019. Preoperative, operative, and postoperative findings and outcomes had to be reported through the national surveillance website.ResultsForty‐three institutes enrolled 295 patients. In 60 patients, associated abnormalities were diagnosed after birth. Among the 235 patients with isolated hydrothorax, the survival rate at 1 year of age was 70.5%. Among these patients, 89% did not require oxygen or other respiratory support. The 1‐year survival rate in complicated cases was 27%. Trisomy 21 was the most common associated problem (40%). Catheter associated problems, including dislocation (25%), obstruction (24%), and preterm rupture of the membranes (6%) were observed, but there were no severe maternal complications. TAS before 29.5 weeks of gestation (odds ratio [OR] 0.16) and skin edema and ascites (OR 0.06) were risk factors for death at one year, whereas appropriate shunt location for >28 days (OR 4.2) was a protective factor.ConclusionWe report a favorable survival rate in fetuses with isolated FHT treated with this double‐basket catheter.